GLOW is a research blend that combines three widely studied peptides in a single lyophilized vial: GHK-Cu (the copper tripeptide), BPC-157 (a stable gastric pentadecapeptide derivative), and TB-500 (a thymosin beta-4 active fragment). The combination lets research teams study copper-peptide matrix biology, soft-tissue signaling, and cytoskeletal/cell-migration pathways together within one preparation. Puritide Research supplies GLOW as a high-purity, research-use-only material for in vitro and animal-model work, backed by third-party-verified certificates of analysis.
Product Specifications
- Application
- Combined tissue-repair, matrix-remodeling, and cell-migration research
- Appearance
- Blue-tinted lyophilized powder in a sealed glass vial (the blue hue reflects the copper(II) in the GHK-Cu component)
- Chemical Formula
- Blend, GHK-Cu: C14H24CuN6O4; BPC-157: C62H98N16O22; TB-500 fragment: C212H350N56O78S
- CAS Number
- Blend, GHK-Cu: 49557-75-7; BPC-157: 137525-51-0; TB-500 (Tβ4 fragment): 77591-33-4
- Molecular Weight
- Blend, GHK-Cu: ~403.92 g/mol; BPC-157: ~1419.53 g/mol; TB-500 fragment: ~4963.44 g/mol
- Synonyms
- GLOW, GHK-Cu / BPC-157 / TB-500 blend, Copper tripeptide + Body Protection Compound + Thymosin beta-4 fragment
- Storage
- Store at ≤25°C, sealed, away from heat, light, and moisture. For extended storage, keep lyophilized and refrigerated or frozen.
What Is GLOW?
GLOW is a physical blend of three distinct research peptides rather than a single molecule. It combines GHK-Cu, the copper(II) complex of glycyl-L-histidyl-L-lysine studied for matrix remodeling; BPC-157, a synthetic peptide derived from a gastric protein fragment studied for soft-tissue and cytoprotective signaling; and TB-500, an active fragment of thymosin beta-4 studied for actin regulation and cell migration.
In experimental settings, the blend is used to investigate these three peptides in parallel, for example, examining matrix synthesis, tissue-repair signaling, and cytoskeletal/angiogenic responses within the same model system. A common formulation supplies 70mg total per vial, combining 50mg GHK-Cu with 10mg BPC-157 and 10mg TB-500.
Present understanding of each component derives from in vitro assays, animal models, and biochemical studies. Findings should be interpreted within their experimental context and not treated as established clinical outcomes. Puritide Research supplies GLOW strictly for laboratory use; it is not approved for human or veterinary application.
Research Use Only
